SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001396814-24-000124
Filing Date
2024-09-27
Accepted
2024-09-27 08:02:24
Documents
13
Period of Report
2024-09-26
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K pcrx-20240926.htm   iXBRL 8-K 27734
  Complete submission text file 0001396814-24-000124.txt   152593

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20240926.xsd EX-101.SCH 1911
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20240926_lab.xml EX-101.LAB 21880
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20240926_pre.xml EX-101.PRE 12518
16 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-20240926_htm.xml XML 2830
Mailing Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609
Business Address 5401 WEST KENNEDY BOULEVARD SUITE 890 TAMPA FL 33609 813-553-6680
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35060 | Film No.: 241330603
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)